Modulus
Device
NUVASIVE, INC.
Total Payments
$8.9M
Transactions
2,460
Doctors
851
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3.2M | 543 | 227 |
| 2023 | $1.9M | 395 | 214 |
| 2022 | $1.9M | 330 | 153 |
| 2021 | $900,910 | 325 | 184 |
| 2020 | $567,951 | 244 | 127 |
| 2019 | $189,497 | 273 | 190 |
| 2018 | $295,174 | 323 | 187 |
| 2017 | $5,741 | 27 | 24 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $8.2M | 306 | 92.7% |
| Consulting Fee | $294,718 | 186 | 3.3% |
| Unspecified | $200,261 | 36 | 2.3% |
| Food and Beverage | $85,300 | 1,788 | 1.0% |
| Travel and Lodging | $58,302 | 127 | 0.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $10,175 | 2 | 0.1% |
| Education | $1,788 | 5 | 0.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 0.0% |
| Entertainment | $231.67 | 9 | 0.0% |
Payments by Type
General
$8.7M
2,424 transactions
Research
$200,261
36 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Cervical Spine (Enrolling by invitation) | Globus Medical, Inc. | $68,059 | 0 |
| An Assessment of the Safety and Performance of the Modulus ALIF System in Patients Undergoing Anterior Lumbar Interbody Fusion | NuVasive, Inc. | $39,730 | 0 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Cervical Spine | NuVasive, Inc. | $38,435 | 0 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Cervical Spine | Globus Medical, Inc. | $29,237 | 0 |
| NUVA.CIB0420: A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the cervical spine | NuVasive, Inc. | $14,276 | 0 |
| An assessment of the safety and performance of the Modulus ALIF System in patients undergoing anterior lumbar interbody fusion. | Globus Medical, Inc. | $5,519 | 0 |
| An Assessment of the Safety and Performance of the Modulus 3D-printed Titanium Interbody Implant in Patients Undergoing eXtreme Lateral Interbody Fusion (XLIF) | NuVasive, Inc. | $2,500 | 0 |
| An assessment of the safety and performance of the Modulus ALIF System in patients undergoing anterior lumbar interbody fusion | Globus Medical, Inc. | $1,558 | 0 |
| A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the cervical spine | NuVasive, Inc. | $917.50 | 0 |
| A Retrospective Review of the Clinical and Radiographic Outcomes Following the Use of the NuVasive Cervical Interbody Implants with Attrax Putty for Degenerative Cervical Pathologies | Globus Medical, Inc. | $28.55 | 0 |
Ad
Manufacturing Companies
- NuVasive, Inc. $5.7M
- Globus Medical, Inc. $3.2M
- NUVASIVE, INC. $5,741
Product Information
- Type Device
- Total Payments $8.9M
- Total Doctors 851
- Transactions 2,460
About Modulus
Modulus is a device associated with $8.9M in payments to 851 healthcare providers, recorded across 2,460 transactions in the CMS Open Payments database. The primary manufacturer is NUVASIVE, INC..
Payment data is available from 2017 to 2024. In 2024, $3.2M was paid across 543 transactions to 227 doctors.
The most common payment nature for Modulus is "Royalty or License" ($8.2M, 92.7% of total).
Modulus is associated with 10 research studies, including "A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Cervical Spine (Enrolling by invitation)" ($68,059).